Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide vs Carbamazepine Monotherapy in Newly Diagnosed Partial Epilepsy
NCT00477295Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of zonisamide in partial epilepsy, sponsored by Eisai Co., Ltd.. Started May 2007; status: completed.
02
Drugs
zonisamide
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT00477295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00477295.